Here's Why Lucid Diagnostics (LUCD) Declined in Q3 [Yahoo! Finance]
Lucid Diagnostics Inc. (LUCD)
Company Research
Source: Yahoo! Finance
A copy of the letter can be downloaded here . In the quarter, Minot Light generated solid returns for limited partners, with a net of 7.6%. However, on a net basis, the performance underperformed the benchmarks, particularly the micro-cap benchmark's 17.1% return. In addition, please check the fund's top five holdings to know its best picks in 2025. In its third-quarter 2025 investor letter, Minot Light Capital Partners highlighted stocks such as Lucid Diagnostics Inc. (NASDAQ: LUCD ). Lucid Diagnostics Inc. (NASDAQ:LUCD) is a US-based commercial-stage medical diagnostics technology company. The one-month return for Lucid Diagnostics Inc. (NASDAQ:LUCD) was 0.92%, and its shares gained 43.92% over the last 52 weeks. On December 23, 2025, Lucid Diagnostics Inc. (NASDAQ:LUCD) stock closed at $1.10 per share, with a market capitalization of $144.209 million. Minot Light Capital Partners stated the following regarding Lucid Diagnostics Inc. (NASDAQ:LUCD) in its third quarter 2025 inves
Show less
Read more
Impact Snapshot
Event Time:
LUCD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LUCD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LUCD alerts
High impacting Lucid Diagnostics Inc. news events
Weekly update
A roundup of the hottest topics
LUCD
News
- Lucid Diagnostics (NASDAQ:LUCD) had its price target raised by analysts at Ascendiant Capital Markets from $8.00 to $8.25. They now have a "buy" rating on the stock.MarketBeat
- Lucid Diagnostics (NASDAQ:LUCD) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer DetectionPR Newswire
- Lucid Diagnostics Inc.'s (NASDAQ:LUCD) largest shareholders are individual investors with 38% ownership, public companies own 30% [Yahoo! Finance]Yahoo! Finance
- Lucid Diagnostics (NASDAQ:LUCD) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
LUCD
Earnings
- 11/12/25 - Miss
LUCD
Sec Filings
- 12/5/25 - Form S-3
- 11/12/25 - Form 8-K
- 11/12/25 - Form 10-Q
- LUCD's page on the SEC website